Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial

Table 5

Comparison of PLT, AST, ALT, BUN, CR, and INR in participants of two groups before and after treatment.

	Baseline	After treatment
PLT, ×10^9/L
Treatment	181.00 ± 32.51	180.95 ± 32.58	0.008	0.994
Control	187.60 ± 41.59	188.98 ± 42.49	−0.188	0.851
AST, U/L
Treatment	19.53 ± 8.04	19.70 ± 7.05	−0.127	0.899
Control	19.23 ± 6.77	18.69 ± 6.27	0.470	0.639
ALT, U/L
Treatment	18.01 ± 5.29	17.63 ± 5.65	0.400	0.690
Control	17.18 ± 5.34	16.52 ± 5.24	0.712	0.478
BUN, mmol/L
Treatment	5.05 ± 1.02	4.91 ± 0.93	0.785	0.434
Control	4.85 ± 0.94	4.84 ± 0.85	0.059	0.953
CR, μmol/L
Treatment	65.98 ± 9.27	64.76 ± 8.18	0.792	0.430
Control	64.95 ± 8.70	63.61 ± 7.07	0.962	0.338
INR, R
Treatment	1.01 ± 0.11	1.00 ± 0.09	0.279	0.780
Control	1.00 ± 0.11	0.99 ± 0.08	0.406	0.685

Notes. Equal variance, analyzed by Levene’s test for equality of variances ; and values were, respectively, statistics and probability which were analyzed by paired -test for the two groups before treatment.